Vitamin K2 Market Overview

The global vitamin K2 market was valued at USD 292.4 million in 2024 and is projected to reach USD 602.0 million by 2030, expanding at a CAGR of 13.5% from 2025 to 2030. Growth is driven by increasing consumer awareness of Vitamin K2’s health benefits, demographic shifts such as an aging population, evolving dietary habits, and mounting scientific evidence supporting its therapeutic applications.

Vitamin K2 is gaining popularity for its crucial role in bone and cardiovascular health, helping direct calcium to bones and away from arteries. As consumers become more proactive in managing their health and preventing chronic diseases, demand for Vitamin K2 supplements continues to rise.

In April 2023, Petrovax Pharm introduced SunDevit in Russia—a new complex combining vitamins D3 and K2—designed to boost immune function and support musculoskeletal health. Such innovations are increasingly common as manufacturers seek to enhance product appeal and efficacy.

The prevalence of osteoporosis and cardiovascular disease, especially among aging populations, further fuels demand. Studies show that Vitamin K2 can reduce fracture risks and prevent arterial calcification. A February 2024 study also linked Vitamin K2 to reduced weight, abdominal fat, and liver fat in mice, underscoring its potential in managing non-alcoholic fatty liver disease (NAFLD).

Order a free sample PDF of the Vitamin K2 Market Intelligence Study, published by Grand View Research.

Ongoing product innovation—including new dosage forms like capsules, tablets, soft gels, and liquid combinations—continues to expand market reach. For instance, MENADIONA launched a USP-grade MK-7 product in January 2021, reinforcing its presence in the nutraceutical sector.

Additionally, government support and favorable regulatory frameworks promote the development of safe and high-quality Vitamin K2 supplements. Scientific discoveries are also revealing potential benefits beyond bone and heart health. A study published in October 2023 in Food & Function found Vitamin K2 supplementation could improve blood sugar regulation and insulin resistance, potentially lowering type 2 diabetes risk.

Key Market Trends & Insights

• North America led the market in 2024, accounting for 35.18% of global revenue. The region benefits from widespread health awareness, rising healthcare spending, and dietary trends favoring plant-based and functional supplements.
• The U.S. market is poised for sustained growth, driven by preventive health measures, especially among older adults.
• By Dosage Form:
  The capsules/tablets segment held a 42.05% share in 2024, favored for their ease of manufacturing, long shelf life, and precise dosing.
• By Indication:
  Bone health dominated the market with a 36.41% share. Vitamin K2's role in calcium metabolism and bone density maintenance makes it a cornerstone in osteoporosis prevention.
• By Product:
  The MK-7 segment led in 2024, driven by its natural origin, higher bioavailability, and longer half-life compared to MK-4. It is widely sourced from fermented foods like natto and linked to cardiovascular protection.

Market Size & Forecast Summary

• 2024 Market Size: USD 292.4 Million
• 2030 Projected Market Size: USD 602.0 Million
• CAGR (2025–2030): 13.5%
• Leading Region (2024): North America

Competitive Landscape

Key players in the vitamin K2 market are focused on expansion, product innovation, and strategic partnerships to enhance their market reach and competitiveness. These include:

• NOW Foods
• Life Extension
• Pharmavite (Nature Made)
• Nestlé (Garden of Life)
• Bronson
• NatureWise
• Solaray
• Natural Factors
• Source Naturals
• MaryRuth Organics

These companies offer a variety of Vitamin K2 formulations, catering to the growing demand in both nutraceutical and functional food sectors.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global Vitamin K2 market is on a strong upward trajectory, fueled by growing interest in preventive health, rising geriatric populations, and increasing scientific validation of K2’s benefits. With a projected CAGR of 13.5%, the market is expected to more than double in size by 2030. Continued product innovation, expanding consumer education, and favorable regulations will play pivotal roles in shaping the future of the Vitamin K2 industry—especially in areas like bone health, cardiovascular wellness, and emerging metabolic applications.